Biocept (BIOC) Reports Q1 Loss Per Share of $0.37

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Biocept (BIOC) Reports Q1 Loss Per Share of $0.37

Biocept Reports First Quarter 2015 Financial Results

May 12, 2015 4:05 PM EDT

Announces Increased Revenues and Strong Year-over-Year Growth in Test Volume

Conference call begins at 4:30 p.m. Eastern time today

SAN DIEGO, May 12, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the diagnosis and treatment of cancer, today reported financial results for the three months ended March 31, 2015.

Recent Business Highlights

Expanded the Company's non-small cell lung cancer (NSCLC) diagnostic capabilities to... More